INTERACTIVE MEDICAL TECHNOLOGIES LTD
SC 13D, 1998-02-04
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: BIO IMAGING TECHNOLOGIES INC, SC 13D, 1998-02-04
Next: NEW AMERICA HIGH INCOME FUND INC, N-2/A, 1998-02-04



<PAGE>
 
                                                   ---------------------------
                                                          OMB APPROVAL
                                                   ---------------------------
                                                   OMB number:       3235-0145
                                                   Expires:    August 31, 1999
                                                   Estimated average burden 
                                                   hours per response... 14.90
                                                   ---------------------------
                                                    



                                 UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C.  20549

                                  SCHEDULE 13D
                   UNDER THE SECURITIES EXCHANGE ACT OF 1934
                            (AMENDMENT NO.      )*  
                                           -----


                    INTERACTIVE MEDICAL TECHNOLOGIES, LTD.
- --------------------------------------------------------------------------------
                                (Name of Issuer)

                     COMMON STOCK         $.001 PAR VALUE
- --------------------------------------------------------------------------------
                        (Title of Class of Securities)

                                   458937109
- --------------------------------------------------------------------------------
                                 (CUSIP Number)

 Bruce W. Barren 11099 Sunset Blvd., Los Angeles, CA 90049-3224 (310) 471-3735
- --------------------------------------------------------------------------------
          (Name, Address and Telephone Number of Person Authorized to
                      Receive Notices and Communications)

                               JANUARY 20, 1998
- --------------------------------------------------------------------------------
            (Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report 
the acquisition which is the subject of this Schedule 13D, and is filing this 
schedule because of Rule 13d-1(b)(3) or (4), check the following box. [_]

Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter 
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).




Potential persons who are to respond to the collection of information contained
in this form are set required to respond unless the form displays a currently
valid OMB control number.
<PAGE>
 
- -----------------------                                  ---------------------
  CUSIP NO. 458937109             SCHEDULE 13D              PAGE 2 OF 3 PAGES
- -----------------------                                  ---------------------
 
- ------------------------------------------------------------------------------
      NAME OF REPORTING PERSON
 1    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

      BRUCE W. BARREN
- ------------------------------------------------------------------------------
      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 2                                                              (a) [_]
      N/A                                                       (b) [_]
                                                 
- ------------------------------------------------------------------------------
      SEC USE ONLY
 3
 

- ------------------------------------------------------------------------------
      SOURCE OF FUNDS (SEE INSTRUCTIONS)
 4    
      SC

- ------------------------------------------------------------------------------
      CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
 5    2(d) or 2(e)
      
      N/A
- ------------------------------------------------------------------------------
      CITIZENSHIP OR PLACE OF ORGANIZATION
 6    
      U.S. CITIZEN

- ------------------------------------------------------------------------------
                          SOLE VOTING POWER
                     7   
     NUMBER OF            19,500,000 
 
      SHARES       -----------------------------------------------------------
                          SHARED VOTING POWER
   BENEFICIALLY      8
                          
     OWNED BY
                   -----------------------------------------------------------
       EACH               SOLE DISPOSITIVE POWER
                     9    
    REPORTING             
 
      PERSON       -----------------------------------------------------------
                          SHARED DISPOSITIVE POWER
       WITH         10
                
          
- ------------------------------------------------------------------------------
      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11  
      19,500,000

- ------------------------------------------------------------------------------
      CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE 
12    INSTRUCTIONS) 
 
 
- ------------------------------------------------------------------------------
      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13    
      7.75%

- ------------------------------------------------------------------------------
      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
14
      IN

- ------------------------------------------------------------------------------

                               Page 2 of 3 pages

<PAGE>
 
                                                                         Page 3
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, DC  20549

                                  Schedule 13D
                   Under the Securities Exchange Act of 1934


Fee enclosed [_] or Amendment No. 

Item 1(a) Name of Issuer:

          INTERACTIVE MEDICAL TECHNOLOGIES, LTD.
          
Item 1(b) Address of Issuer's Principal Executive Offices:

          2139 Pontius Ave., Los Angeles, CA 90025
          
Item 2(a) Name of Person(s) Filing:

          Bruce W. Barren
         
Item 2(b) Address of Principal Business Office:
          
          11099 Sunset Blvd., Los Angeles, CA 90049-3224
          
Item 2(c) Citizenship:   U.S. Citizen

Item 2(d) Title of Class of Securities:  Common Stock

Item 2(e) CUSIP Number:  458937109

Item 3    The person(s) filing is(are):

          (b)  [_]  Bank as defined in Section 3(a)(6) of the Act.

          (e)  [_]  Investment Adviser registered under Section 203 of the 
                    Investment Advisers Act of 1940.

          (g)  [_]  Parent Holding Company in accordance with 
                    Section 240.13d-1(b)(1)(ii)(G).

Item 4    Ownership

          (a) Amount Beneficially Owned:
              See item 9, pg. 2 and 3

          (b) Percent of Class:  See item 11, pg. 2 and 3

          (c) Number of shares as to which such person has:

              i)   sole power to vote or to direct the vote 
                   See item 5, pg. 2 and 3

              ii)  shared power to vote or to direct the vote  None

              iii) sole power to dispose or to direct the disposition of  
                   See item 7, pg. 2 and 3

              iv)  shared power to dispose or to direct the disposition of 
                   None - beneficial ownership disclaimed pursuant to Rule 13d-4

Item 5    Ownership of 5% or Less of a Class:  N/A

Item 6    Ownership of More than 5% on Behalf of Another Person:  N/A

Item 7    Identification and Classification of the Subsidiary Which Acquired the
          Security Being Reported on By the Parent Holding Company

(1)       Capital Research and Management Company is an Investment Adviser 
          registered under Section 203 of the Investment Advisers Act of
          1940 and is a wholly owned subsidiary of The Capital Group, Inc.

(2)       Capital Guardian Trust company is a Bank as defined in Section 3(a)(6)
          of the Act and a wholly owned subsidiary of The Capital Group, Inc.

(3)       Capital International S.A. (CISA) does not fall within any of the
          categories described in Rule 13d-1(b)(ii)(A-F) but its holdings of any
          reported securities come within the five percent limitations as set
          forth in a December 15, 1986 no-action letter from the Staff of the
          Securities and Exchange Commission to The Capital Group, Inc.  CISA is
          a wholly owned subsidiary of The Capital Group, Inc.

(4)       Capital International Limited (CIL), does not fall within any of the
          categories described in Rule 13d-1(b)(ii)(A-F) but its holding of any
          reported securities come within the five percent limitation as set
          forth in a December 15, 1986 no-action letter from the Staff of the
          Securities and Exchanged Commission to The Capital Group, Inc.  CIL is
          a wholly owned subsidiary of The Capital Group, Inc.

(5)       Capital International Research and Management, Inc. dba Capital
          International, Inc. is an investment Adviser registered under Section
          203 of the Investment advisers Act of 1940 and is a wholly owned
          subsidiary of The Capital Group, Inc.

Item 8    Identification and Classification of Members of the Group:  N/A

Item 9    Notice of Dissolution of the Group:  N/A

Item 10   Certification

          By signing below, I certify that, to the best of my knowledge and 
belief, the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in any transaction having
such purpose or effect.

          Signature

          After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.

Date:  February 3, 1998


Signature:   /s/ Bruce Barren
             ----------------------------------------------

Name/Title:  
             ----------------------------------------------

             
             -----------------------------------------------


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission